Personal Services · Consumer Cyclical
Chairman, Board Member
2023-12-28–present
Chairman
Dror Ortho-Design, Inc. (DROR)Board Member
NRX Pharmaceuticals, Inc. (NRXP)Board Member
Dror Ortho-Design, Inc. (DROR)Equibles does not estimate personal net worth.
Get an email with a short summary when Dror Ortho-Design, Inc. publishes a filing, an earnings call transcript or a press release.
Get DROR alertsChaim Hurvitz is recorded as Board Member at Dror Ortho-Design, Inc. (DROR) since December 28, 2023, Chairman at Dror Ortho-Design, Inc. (DROR) and Board Member at NRX Pharmaceuticals, Inc. (NRXP). The newest filing on record that lists Chaim Hurvitz as Chairman at Dror Ortho-Design, Inc. (DROR) is dated December 18, 2023. The newest filing on record that lists Chaim Hurvitz as Board Member at NRX Pharmaceuticals, Inc. (NRXP) is dated February 23, 2026. NRX Pharmaceuticals, Inc. reported in an 8-K filed March 24, 2026 that Chaim Hurvitz was appointed Class I director, effective March 23, 2026. Dror Ortho-Design, Inc. reported in an 8-K filed January 4, 2024 that Chaim Hurvitz was appointed Director, effective December 28, 2023. Dror Ortho-Design, Inc. reported in an 8-K filed August 14, 2023 that Chaim Hurvitz was appointed Chairman of our board of directors, effective January 17, 2012. Equibles holds 5 filed executive changes naming Chaim Hurvitz; each is listed under recent activity with its source filing. Dror Ortho-Design, Inc. is classified in the Personal Services industry within the Consumer Cyclical sector. NRX Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Dror Ortho-Design, Inc. includes Eliyahu (Lee) Haddad (CEO and Board Member), Lee Haddad (CEO and Board Member), Moshe Shvets (CTO and Board Member) and 2 others.
“The Company's stockholders elected Chaim Hurvitz and Michael Taylor as Class I directors to serve until the 2028 annual meeting of stockholders and until such director's successor has been duly elected and qualified.”
“Election of the five directors named in the Proxy Statement to the Board to serve until the annual meeting of stockholders in 2024 or until each one's respective successor has been duly elected and qualified.”
2023-12-28–present
Start not stated–present
Last confirmed December 18, 2023
Start not stated–present
Last confirmed February 23, 2026
Personal Services · Consumer Cyclical
Chairman, Board Member
2023-12-28–present